关注
Jennifer Ho
Jennifer Ho
Associate Professor of Medicine
在 bidmc.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Heart disease and stroke statistics—2022 update: a report from the American Heart Association
CW Tsao, AW Aday, ZI Almarzooq, A Alonso, AZ Beaton, MS Bittencourt, ...
Circulation 145 (8), e153-e639, 2022
39012022
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
D Preiss, SRK Seshasai, P Welsh, SA Murphy, JE Ho, DD Waters, ...
Jama 305 (24), 2556-2564, 2011
18912011
Heart disease and stroke statistics—2023 update: a report from the American Heart Association
CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson, P Arora, CL Avery, ...
Circulation 147 (8), e93-e621, 2023
16682023
Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction
R Santhanakrishnan, NA Wang, MG Larson, JW Magnani, DD McManus, ...
Circulation 133 (5), 484-492, 2016
8042016
Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community
JE Ho, C Liu, A Lyass, P Courchesne, MJ Pencina, RS Vasan, MG Larson, ...
Journal of the American College of Cardiology 60 (14), 1249-1256, 2012
7892012
Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study
TJ Wang, KC Wollert, MG Larson, E Coglianese, EL McCabe, S Cheng, ...
Circulation 126 (13), 1596-1604, 2012
5632012
Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction
CW Tsao, A Lyass, D Enserro, MG Larson, JE Ho, JR Kizer, JS Gottdiener, ...
JACC: heart failure 6 (8), 678-685, 2018
4902018
Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials
DD Waters, JE Ho, DA DeMicco, A Breazna, BJ Arsenault, CC Wun, ...
Journal of the American College of Cardiology 57 (14), 1535-1545, 2011
4892011
2-Aminoadipic acid is a biomarker for diabetes risk
TJ Wang, D Ngo, N Psychogios, A Dejam, MG Larson, RS Vasan, ...
The Journal of clinical investigation 123 (10), 4309-4317, 2013
4542013
American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee
CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson, P Arora, CL Avery, ...
Heart disease and stroke statistics-2023 update: a report from the American …, 2023
4292023
Using methods from the data-mining and machine-learning literature for disease classification and prediction: a case study examining classification of heart failure subtypes
PC Austin, JV Tu, JE Ho, D Levy, DS Lee
Journal of clinical epidemiology 66 (4), 398-407, 2013
4062013
Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction
JE Ho, A Lyass, DS Lee, RS Vasan, WB Kannel, MG Larson, D Levy
Circulation: heart failure 6 (2), 279-286, 2013
3672013
Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community
CSP Lam, A Lyass, E Kraigher-Krainer, JM Massaro, DS Lee, JE Ho, ...
Circulation 124 (1), 24-30, 2011
3532011
The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF
N Savji, WC Meijers, TM Bartz, V Bhambhani, M Cushman, M Nayor, ...
JACC: Heart Failure 6 (8), 701-709, 2018
3462018
A genome-wide association study of the human metabolome in a community-based cohort
EP Rhee, JE Ho, MH Chen, D Shen, S Cheng, MG Larson, A Ghorbani, ...
Cell metabolism 18 (1), 130-143, 2013
3302013
Predicting heart failure with preserved and reduced ejection fraction: the international collaboration on heart failure subtypes
JE Ho, D Enserro, FP Brouwers, JR Kizer, SJ Shah, BM Psaty, TM Bartz, ...
Circulation: Heart Failure 9 (6), e003116, 2016
3182016
Genome‐wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease
C Yao, G Chen, C Song, J Keefe, M Mendelson, T Huan, BB Sun, A Laser, ...
Nature communications 9 (1), 3268, 2018
3062018
Galectin-3 activation and inhibition in heart failure and cardiovascular disease: an update
N Suthahar, WC Meijers, HHW Silljé, JE Ho, FT Liu, RA de Boer
Theranostics 8 (3), 593, 2018
2722018
Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study
N Amabile, S Cheng, JM Renard, MG Larson, A Ghorbani, E McCabe, ...
European heart journal 35 (42), 2972-2979, 2014
2622014
Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes
DD Waters, JE Ho, SM Boekholdt, DA DeMicco, JJP Kastelein, M Messig, ...
Journal of the American College of Cardiology 61 (2), 148-152, 2013
2532013
系统目前无法执行此操作,请稍后再试。
文章 1–20